GW9662
Cat.No:IG1070 Solarbio
CAS:22978-25-2
Molecular Formula:C13H9ClN2O3
Molecular Weight:276.68
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Cell Cycle > GW9662CAS:22978-25-2
Molecular Formula:C13H9ClN2O3
Molecular Weight:276.68
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
| CAS | 22978-25-2 |
| Name | GW9662 |
| Molecular Formula | C13H9ClN2O3 |
| Molecular Weight | 276.68 |
| Solubility | Soluble in DMSO ≥10mg/mL |
| Purity | HPLC≥98% |
| Appearance | Light yellow to yellow Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 636-590-7 |
| MDL | MFCD01215270 |
| SMILES | O=C(NC1=CC=CC=C1)C2=CC([N+]([O-])=O)=CC=C2Cl |
| Target Point | PPAR |
| Passage | Cell Cycle;DNA Damage/DNA Repair;Metabolic Enzyme&Protease |
| Background | GW9662 is a potent and selective PPARγ antagonist. |
| Biological Activity | GW9662是有效,选择性的 PPARγ 拮抗剂,IC50值为3.3 nM,比PPARα和PPARδ的选择性高10倍和1000倍[1-4]。 |
| IC50 | PPARα:32nM;PPARγ:3.3nM;PPARδ:2000nM [1-4] |
| Data Literature Source | [1]. Leesnitzer LM,et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry. 2002 May 28;41(21):6640-50. [2]. Seargent JM,et al. GW9662,a potent antagonist of PPARgamma,inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARgamma agonist rosiglitazone,independently of PPARgamma activation. Br J Pharmacol. 2004 Dec;143(8):933-7. [3]. Sato K,et al. PPARγ antagonist attenuates mouse immune-mediated bone marrow failure by inhibition of T cell function.Haematologica. 2016 Jan;101(1):57-67. [4]. Collino M,et al. The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion. Kidney Int. 2005 Aug;68(2):529-36 |
| Unit | Piece |
| Specification | 5mg 10mM*1mL in DMSO 10mg 20mg 50mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download